XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities:    
Net loss $ (81) $ (2,946)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 2
Stock-based compensation 1,666 203
Changes in lease liability 9 (16)
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 658 2,020
Accounts payable, accrued and other current liabilities (5,499) 254
Net cash used in operating activities (3,247) (483)
Investing activities:    
Purchase of property, plant and equipment
Net cash used in investing activities
Financing activities:    
Costs from issuing common stock and pre-funded warrants (248) (79)
Proceeds, net of issuance costs, from issuing common stock and pre-funded warrants, net 3,894
Net cash provided by (used) in financing activities 3,646 (79)
Effect of exchange rate changes on cash and cash equivalents (86) (18)
Net increase (decrease) in cash and cash equivalents 313 (580)
Cash and cash equivalents, beginning of period 3,137 3,378
Cash and cash equivalents, end of period 3,450 2,798
Cash received during the period for:    
Interest 9 1
Research & development tax credits 2,925
Cash paid during the period for:    
Interest 4
Taxes $ 2
Noncash financing activities:    
Accrual of preferred stock dividends $ $